Analysis of the key themes driving M&A activity reveals that immuno-oncology accounted for 6 pharmaceutical deals announced in Q3 2023, worth a total value of $535.7m. The $500m acquisition of Ferring International Center by Royalty Pharma Plc was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q3 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations.
Read the full article: How Immuno-Oncology M&A Performed in the Pharmaceutical Industry in Q3 2023 //
Source: https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/ma-activity-immuno-oncology-pharmaceutical-industry-3